Cargando…

Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease

Detalles Bibliográficos
Autores principales: Singh, Pawan Kumar, Kumar, Rajender, Bal, Amanjit, Gupta, Nalini, Kapoor, Rakesh, Prasad, Kuruswamy Thurai, Singh, Navneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998025/
https://www.ncbi.nlm.nih.gov/pubmed/32031456
http://dx.doi.org/10.1200/JGO.19.00357

Ejemplares similares